Albireo Earning Before Interest and Taxes EBIT from 2010 to 2023

Summary

ALBODelisted Stock

USD 44.15 0.75 1.67%

Albireo Pharma Earning Before Interest and Taxes EBIT yearly trend continues to be very stable with very little volatility. Earning Before Interest and Taxes EBIT is likely to drop to -19,516,216. During the period from 2010 to 2023, Albireo Pharma Earning Before Interest and Taxes EBIT quarterly data regression pattern had range of 91,225,000 and median of (19,516,216). Albireo Pharma Weighted Average Shares is very stable at the moment as compared to the past year. Albireo Pharma reported last year Weighted Average Shares of 22.1 Million. As of 25th of March 2023, Weighted Average Shares Diluted is likely to grow to about 23.8 M, while Consolidated Income is likely to drop (33 M).

Check Albireo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Albireo main balance sheet or income statement drivers, such as Direct Expenses of 1.2 M, Cost of Revenue of 1.2 M or Gross Profit of 48.7 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0502, PPandE Turnover of 67.56 or Receivables Turnover of 6.79. Albireo financial statements analysis is a perfect complement when working with Albireo Pharma Valuation or Volatility modules. It can also supplement various Albireo Pharma Technical models . Check out Trending Equities.

Albireo Earning Before Interest and Taxes EBIT Breakdown

Showing smoothed Earning Before Interest and Taxes EBIT of Albireo Pharma with missing and latest data points interpolated. Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.Albireo Pharma's Earning Before Interest and Taxes EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Albireo Pharma's overall financial position and show how it may be relating to other accounts over time.

Earning Before Interest and Taxes EBIT

10 Years Trend

Down

Slightly volatile

Compare to Others All Fundamentals

Earning Before Interest and Taxes EBIT

Timeline

Albireo Earning Before Interest and Taxes EBIT Regression Statistics

	Arithmetic Mean	(26,916,673)
	Geometric Mean	20,094,756
	Coefficient Of Variation	(89.42)
	Mean Deviation	16,313,569
	Median	(19,516,216)
	Standard Deviation	24,067,607
	Range	91,225,000
	R-Value	(0.35)
	R-Squared	0.12
	Significance	0.22
	Slope	(2,015,644)

Albireo Earning Before Interest and Taxes EBIT History

	2023	-19.5 M
	2022	-18.1 M
	2021	-20.1 M
	2020	-96.3 M
	2019	-57.4 M
	2018	-41.3 M
	2017	-24.2 M
	2016	-15 M
	2014	-5 M
	2013	-14.1 M
	2012	-19.3 M

About Albireo Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Albireo Pharma income statement, its balance sheet, and the statement of cash flows. Albireo Pharma investors use historical funamental indicators, such as Albireo Pharma's Earning Before Interest and Taxes EBIT, to determine how well the company is positioned to perform in the future. Although Albireo Pharma investors may use each financial statement separately, they are all related. The changes in Albireo Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Albireo Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Albireo Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Albireo Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for 2023
Earning Before Interest and Taxes EBIT	-18.1 M	-19.5 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	-17.8 M	-19.3 M
Earnings before Tax	-30.6 M	-33 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Albireo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Options Analysis Now

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios

All Next

Launch Module

Check out Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.

	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC